Innovation. Integrity. Impact.
Driven by scientific curiosity and deep empathy, our team works at the intersection of cutting-edge biotechnology and human need. Every discovery, every collaboration, every breakthrough is guided by our commitment to improving health outcomes for all.
Sarah Alsuleiman, BS
Research & Development Scientist
Sarah Alsuleiman is a driven and accomplished molecular biologist whose research journey has centered on infectious disease, immune system modulation, and translational science. She brings a wealth of laboratory experience to her role as Research & Development Scientist at Athari BioSciences, where she supports the development of advanced diagnostics and immunity surveillance tools. Sarah’s academic foundation was built at the University of Nebraska at Omaha, where she completed a B.S. in Molecular and Biomedical Biology and earned national recognition as a Barry Goldwater Scholar and NIH INBRE Fellow for her work in host-pathogen interactions and immunomodulatory drug development.
Sarah was awarded a prestigious Postbaccalaureate IRTA Fellowship at the NIH, where she investigated microbial pathogenesis and immune hijacking mechanisms in Legionella pneumophila. Her contributions earned her one of only two institute-wide NIH Intramural Program for Developing Talent Scholars Awards and a semifinalist placement in the NICHD Three Minute Talk (TMT) Competition.
Sarah’s commitment to translational impact led her to industry roles at Polaris Genomics and ultimately to Athari BioSciences, where she applies her diverse experiences in bench science, public health, and bioentrepreneurship. A graduate of the Translational Science Training Program at NCATS and a NASA Space Grant Fellow, she is fueled by a deep passion for accelerating scientific discovery to improve human health. Her work is grounded in curiosity, scientific rigor, and a commitment to innovation that moves healthcare forward.
Lauryn Mitchell, MSB
Scientific Project Manager
Lauryn Mitchell is a skilled scientific project manager whose expertise spans product development, laboratory operations, and biotechnology management. At Athari BioSciences, Lauryn plays a pivotal role in aligning scientific strategy with execution, managing cross-functional teams, and advancing diagnostic development efforts. Her leadership contributed to the successful implementation of a novel Neutralizing Antibody (NAb) test for SARS-CoV-2 —all while maintaining strict adherence to CLIA, GMP, and GCP standards.
Lauryn brings both scientific rigor and business acumen to her work, with a background that includes experience at Catalent Pharma Solutions, where she supported end-to-end pharmaceutical formulation and technical documentation. Her ability to bridge communication between scientific teams and executive leadership ensures that projects remain on time, on budget, and aligned with strategic goals. Lauryn’s technical expertise includes molecular diagnostics, data analysis using REDCap and GraphPad Prism, and regulatory compliance across FDA and ISO frameworks.
She earned her Bachelor of Arts in Psychology and Neuroscience from Elizabethtown College and a Master of Science in Biotechnology and Management from Mount St. Mary’s University. Her research has been published in the Journal of Visualized Experiments, and she has presented at the Eastern Psychological Association Conference. Known for her collaborative approach and passion for innovation, Lauryn continues to help shape transformative solutions that improve patient outcomes.
Linda D. Chilin, MS
Associate Research Scientist
Linda D. Chilin is an accomplished research scientist whose career reflects a deep commitment to advancing diagnostic and therapeutic innovation through translational science. As an Associate Research Scientist at Athari BioSciences, Linda leads the laboratory’s CLIA validation studies and contributes to the development of cancer drug therapeutics. She plays a critical role in training new staff and mentoring future biomedical professionals through Athari Bio’s Internship Summer Program, where she brings scientific rigor and passion to STEMM education.
Linda is currently pursuing her Ph.D. in Biosciences at George Mason University, where her research has focused on infectious diseases and cancer biology. Her notable contributions include the development of the Ha-CoV-2 Neutralization Assay Platform—an innovative hybrid alphavirus-SARS-CoV-2 pseudovirion system that enables rapid quantification of variant infectivity and neutralizing antibodies. This platform is now used at Athari Bio for SARS-CoV-2 diagnostics and research. Her scientific portfolio includes co-authorship on multiple peer-reviewed publications related to HIV, COVID-19, and antiviral discovery.
In addition to her research expertise, Linda previously served as Lab Manager for the Center for Infectious Disease Research at George Mason University, where she coordinated safety protocols, laboratory operations, and student training. She has extensive experience with molecular biology techniques including PCR, cell culture, transfection, and flow cytometry, and has supported major discoveries such as the identification of the SHREK family of broad-spectrum virion inactivators.
Linda holds a Bachelor of Science in Global and Community Health, a Master of Science in Biology, and is fluent in both Spanish and English.
Mahaniya Srinivasan, BS
Associate Research Scientist
Mahaniya Srinivasan brings a data-driven lens to scientific innovation, combining her background in bioinformatics and biotechnology with a passion for advancing cancer research and therapeutic discovery. As an Associate Research Scientist at Athari BioSciences, Mahaniya supports high-impact projects at the intersection of computational biology and laboratory experimentation. Her role includes conducting cancer-focused studies, analyzing high-throughput biological data using Python and Excel, and contributing to the development of competitive grant proposals that align with biomedical research priorities.
Prior to joining Athari Bio, Mahaniya served as a research assistant in the Department of Anatomy and Neurobiology at Virginia Commonwealth University (VCU), where she contributed to traumatic brain injury studies by applying bioinformatics approaches to interpret complex neuroimaging and protein marker data. She also supported undergraduate students as a teaching assistant in VCU’s Department of Bioinformatics, guiding learners through Python programming and its applications in biological research.
Mahaniya’s contributions have enriched both scientific understanding and operational excellence. At Athari Bio, her work in cancer biology and funding strategy supports the organization’s mission to accelerate discovery and expand access to diagnostics and therapeutics nationwide.
She earned her Bachelor of Science in Bioinformatics from Virginia Commonwealth University. In addition to her scientific endeavors, Mahaniya remains actively involved in outreach programs.
Sanskruthi Sreepangi, MS
Associate Research Scientist
Sanskruthi Sreepangi is a dedicated molecular biologist whose work bridges infectious disease research, immunology, and therapeutic innovation. As an Associate Research Scientist at Athari BioSciences, she brings hands-on expertise in virology, antiviral drug screening, and host-pathogen interactions—skills cultivated through intensive work in BSL-2 environments with preliminary BSL-3 training. Her contributions span from bench science to mentorship, routinely supporting lab operations, training emerging scientists, and conducting high-impact research aligned with Athari Bio’s commitment to healthcare and innovation.
Sanskruthi’s academic journey began and continues at George Mason University, where she earned her Bachelor of Science in Biology, graduating summa cum laude, and is completing her Master of Science in Molecular Biology. Her research has explored novel antiviral strategies, including siRNA-mediated knockdowns and ubiquitination mechanisms targeting Venezuelan Equine Encephalitis Virus (VEEV). She has presented her findings at national scientific meetings such as the Military Health System Research Symposium and the Chemical and Biological Defense Science & Technology Conference and is the first author of a peer-reviewed publication focused on host-driven antiviral pathways.
Her scientific curiosity is matched by her collaborative spirit and passion for biosurveillance, drug discovery, and public health innovation. With a drive to uncover therapeutic solutions for emerging viral threats, Sanskruthi represents the next generation of scientists committed to protecting global health.
Jacob Lockey
Research Scientist I
Jacob Lockey is an emerging scientist and biomedical engineering student whose research contributions to assay development and laboratory automation reflect his passion for innovation, problem-solving, and precision. As an Associate Research Scientist at Athari BioSciences, Jacob supports scientific efforts at the intersection of engineering, molecular biology, and high-throughput diagnostics. He has played a key role in advancing projects aimed at antibiotic resistance detection and automation of neutralizing antibody testing using the Opentrons OT-2 robotic platform. His work blends hands-on technical execution with thoughtful experimentation, resulting in more efficient workflows and data-driven improvements in assay reproducibility and throughput.
Jacob is particularly drawn to solutions that enhance scalability and reduce human error in diagnostic science. He has collaborated on the design and optimization of small molecule screening platforms to combat Gram-negative bacterial infections and has contributed to the development of custom prosthetic and biomechanical models as part of his academic pursuits. He applies programming skills in Python and MATLAB alongside CAD design and mechanical systems knowledge to support interdisciplinary research.
Jacob is currently pursuing a Bachelor of Science in Biomedical Engineering at George Mason University, where he is enrolled in the Honors College and Accelerated Master’s Program.